It was part of a 3m sale of two drugs stocks by the UK's biggest quoted venture investor, as MDY snapped up 1.2% of ProStrakan at 61.5p a share, Thursday's closing price. The shares, which doubled to top 100p between March and August last year, firmed ...


Recent comments
5 years 50 weeks ago
15 years 14 weeks ago
15 years 15 weeks ago
15 years 15 weeks ago
15 years 32 weeks ago
15 years 32 weeks ago
15 years 39 weeks ago
16 years 5 weeks ago
16 years 39 weeks ago
16 years 39 weeks ago